Sabby Management’s MacroGenics MGNX Stock Holding History

Sabby Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-149,839	Closed	-$3.26M	–	276
2014 Q2	$3.26M	Sell	149,839 -714	-0.5%	-$15K	0.14%	77
2014 Q1	$4.19M	Buy	+150,553	New	+$5.32M	0.23%	73

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sabby Management's MGNX Position: Q3 2014 in Review

Sabby Management sold out of MacroGenics (MGNX) in Q3 2014, closing a stake of 149,839 shares — an estimated $3.26M sold.

Sabby Management first reported a position in MGNX in Q1 2014 and held it in 2 quarters. The position peaked at $4.19M in Q1 2014. 85 funds tracked by Wall St. Rank hold MGNX as of Q3 2014.

Sabby Management reported no remaining MacroGenics position as of Q3 2014 after selling out during the quarter.
Sabby Management sold 149,839 MacroGenics shares in Q3 2014, an estimated $3.26M.
Sabby Management first reported a position in MacroGenics in Q1 2014 and held it in 2 quarters.
Sabby Management's MacroGenics position peaked at $4.19M in Q1 2014.
85 funds tracked by Wall St. Rank held MacroGenics as of Q3 2014.

Based on Sabby Management's 13F filing for Q3 2014, filed 14 Nov 2014.